baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Blueprint Medicines Corp/ US09627Y1091 /

2024-04-19 9:59:56 PM	Chg. -2.03	Volume	Bid-	Ask-	High	Low
86.87USD	-2.28%	52,634 Turnover: 4.56 mill.	-Bid Size: -	-Ask Size: -	89.90	84.72

GlobeNewswire 03-11 FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer

GlobeNewswire 03-06 Aerovate Therapeutics Board of Directors Appoints Habib Dable as Board Chair

GlobeNewswire 02-28 Recludix Pharma to Participate in Two Investor Conferences in March

GlobeNewswire 02-06 Recludix Pharma to Present at Two Investor Conferences in February

GlobeNewswire 01-17 Day One Announces Two New Appointments to Board of Directors

GlobeNewswire 2023-11-15 T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to tr...

GlobeNewswire 2023-11-09 Recludix Pharma to Present at Two Investor Conferences in November

GlobeNewswire 2023-10-31 Recludix Pharma Presents Preclinical Data Demonstrating Strong Efficacy and Favorable Safety Profile...

GlobeNewswire 2023-10-17 Recludix Pharma Presents Preclinical Data from its STAT3 Inhibitor Program at the International Conf...

GlobeNewswire 2023-08-30 Recludix Pharma to Participate in Multiple Investor Conferences in September

GlobeNewswire 2023-08-29 Better Life Partners Raises $26.5 Million in Series B Financing to Amplify and Scale its Hybrid Whol...

GlobeNewswire 2022-03-10 Immuneering Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update...

GlobeNewswire 2022-03-01 Zai Lab Announces Financial Results and Corporate Updates for Twelve Months Ended December 31, 2021

GlobeNewswire 2022-01-18 Immuneering Strengthens Board of Directors with the Appointment of Diana F. Hausman, M.D.

GlobeNewswire 2022-01-10 Fulcrum Therapeutics® Announces Upcoming Milestones to Support Its Mission of Treating the Root Caus...

GlobeNewswire 2022-01-06 Recludix Pharma Announces Scientific Advisory Board

GlobeNewswire 2021-12-17 Gritstone Announces Changes to Its Board of Directors

GlobeNewswire 2021-12-08 Acrivon Therapeutics Announces its Scientific Advisory Board with Renowned Oncology Thought Leaders

GlobeNewswire 2021-11-15 Recludix Pharma Launches with $60 Million Series A to Support Innovative Platform to Discover and De...

GlobeNewswire 2021-11-09 Zai Lab Announces Third Quarter 2021 Financial Results and Corporate Updates

GlobeNewswire 2021-11-09 Zai Lab and Blueprint Medicines Announce Strategic Collaboration and License Agreement for BLU-945 a...

GlobeNewswire 2021-11-01 Tango Therapeutics Announces Appointment of Dr. Marc Rudoltz as Chief Medical Officer and Doug Barry...

GlobeNewswire 2021-08-12 Lyell Immunopharma Reports Second Quarter 2021 Financial Results and Business Highlights

GlobeNewswire 2021-07-26 AYVAKIT® (avapritinib) Companion Diagnostic Test Enters Priority Review and Approval Process in Chin...

GlobeNewswire 2021-07-21 Executive Women In Bio Selects Women Ready to Change the Boardroom

Blueprint Medicines Corp/ US09627Y1091 /

If you wish to receive reply to your feedback, please provide your email address.